Accounts show that Ardmac Group Ltd’s pre-tax profits declined by 40pc from €6.17m to €3.72m in 2020. Ardmac counts Covid-19 vaccine maker Pfizer as one of its industry clients and the group’s Irish business was hardest hit by the pandemic where revenues declined by 40pc from €69.58m to €38.23m. The group’s ‘rest of Europe’ business performed strongly in 2020 where revenues increased marginally from €89.73m to €90.85m. Staff costs in 2020 increased €1.8m from €26.74m to €28.54m. At the end of 2020, Ardmac had accumulated profits of €33.46m while its cash increased from €27.8m to €34.19m.

Source: Irish Independent January 07, 2022 04:10 UTC